Subsequently, the Kaplan-Meier Plotter, UALCAN, and OncoLnc databases were used to study the prognostic role of PTTG3P in breast cancer, and the analytic results displayed that high expression of PTTG3P indicated poor RFS, OS, and DMFS. This evidence concerns the gene PTTG3P and breast carcinoma.